Pharming group reports on results of the 2025 extraordinary general meeting of shareholders

Leiden, the netherlands, march 4, 2025: pharming group n.v. (“pharming” or “the company”) (euronext amsterdam: pharm/nasdaq: phar) announces today that the extraordinary general meeting of shareholders (egm) has adopted all proposals on the egm agenda.
GM Ratings Summary
GM Quant Ranking